Pramana

Executive Summary

Pramana is a San Francisco-based startup leveraging AI to digitize pathology glass slides, aiming to unlock decades of diagnostic data for precision medicine. Founded in 2020, the company addresses a critical bottleneck in pathology: hundreds of millions of slides remain in analog form, limiting their use in computational analysis and personalized treatment. By converting these slides into high-resolution digital images and applying machine learning, Pramana can enable faster, more accurate diagnoses and support drug development through biomarker discovery. Although still in early stages with no disclosed funding or partnerships, its technology aligns with the growing trend toward AI-powered digital pathology, a market expected to expand rapidly as healthcare systems seek efficiency and data-driven insights. If successful, Pramana could become a key infrastructure player in the transition from glass to digital pathology, potentially improving patient outcomes and reducing diagnostic errors.

Upcoming Catalysts (preview)

• Q2 2026Series A Funding Announcement70% success
• Q3 2026Strategic Partnership with Major Hospital Network60% success
• Q4 2026FDA 510(k) Clearance for AI Pathology Algorithm40% success